NCT00576316已完成4 期
Symbicort Maintenance And Reliever Therapy - Experience in Real Life Setting in Malaysia - SMARTER Study
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 201
- 试验地点
- 1
- 主要终点
- Change in Satisfaction With Asthma Treatment Questionnaire (SATQ) Scores From Baseline to the Mean of 3 Months and 6 Months After Patient Was Initially Treated With SMART
研究概览
简要总结
The purpose of the study is to evaluate the satisfaction level of patients using the Symbicort SMART approach for their asthma management.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of asthma for past 6 months and treated with inhaled glucocorticosteroids for at least 3 months.
- •Patients who asthma is classified as uncontrolled or partially controlled as defined by GINA 2006 guidelines.
排除标准
- •Patients already on Symbicort SMART treatment.
- •Patients who has respiratory tract infection 30 days before study enrolment.
结局指标
主要结局
Change in Satisfaction With Asthma Treatment Questionnaire (SATQ) Scores From Baseline to the Mean of 3 Months and 6 Months After Patient Was Initially Treated With SMART
时间窗: 6 months after each patient was initially treated with Symbicort SMART
Difference/change in SATQ score between baseline and mean of 3 months and 6 months after SMART treatment as analysed by paired t-test. SATQ is a patient reported questionnaire which consists of 26 questions and scored to a scale of 1-7, the higher score indicating a greater level of satisfaction
次要结局
- Changes in Asthma Control Questionnaire (ACQ-5) Score From Baseline to the Mean of 3 Months and 6 Months After Patient Was Initially Treated With SMART(6 months after each patient was initially treated with Symbicort SMART)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Symbicort SMART (Symbicort Maintenance And Reliever Therapy)AsthmaNCT00523679AstraZeneca2,000
已完成
4 期
Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across AsiaAsthmaNCT00939341AstraZeneca862
已完成
不适用
Symbicort SMART Satisfaction From Patient Perspective 2009AsthmaNCT00946452AstraZeneca205
已完成
3 期
Gemini Symbicort pMDIMild or Moderate AsthmaNCT00646516AstraZeneca615
已完成
不适用
A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical PracticeBronchial AsthmaNCT00505388AstraZeneca5,137